Hi Ray
I have just had the chance to read your comments on this matter
and support the thesis that you have proposed. I would be
interested in your comments on the differences between clinical
pharmacy services (CPS) and pharmaceutical care services (PCS).
I raise this in the context of payment for cognitive services and
third party reimbusement. My impression is that CPS will be the
more accepted basis for payment since, as they are mostly
process related, they are easier to define, monitor and understand
by all concerned. The tendency to ignore outcomes, commitment
and care because they are more difficult to monitor and be valued
suggests that PCS will have difficulty getting to first base on the
payment list.
Cheers
Billy
Billy Futter
Associate Professor
Faculty of Pharmacy
Rhodes University, Grahamstown, South Africa
email B.Futter@ru.ac.za
|